英文名稱 Anti-CARD17/INCA

中文名稱 凋亡加強(qiáng)結(jié)構(gòu)域蛋白17抗體

濃 度 1mg/1ml

規(guī) 格 0.2ml/200μg

抗體來(lái)源 Rabbit

克隆類型 polyclonal

交叉反應(yīng) Human

產(chǎn)品類型 一抗

研究領(lǐng)域 細(xì)胞生物 細(xì)胞凋亡

蛋白分子量 predicted molecular weight: 12kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humnaCARD17/INCA

亞 型 IgG

純化方法 affinity purified by Protein A

儲(chǔ) 存 液 Preservative: 15mM Soium zde, Constituents: 1% BSA,0.01M PBS, pH 7.4

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件 Store at -610 °C for oneyear.

別 名 CAR17_HUMAN; CARD 17; CARD17; Caspase 1 inhibitor;Caspase recruitment domain containing protein 17; Caspase recruitmentdomain-containing protein 17; Caspase-1 inhibitor INCA; Caspase1 inhibitor;Inhibitory caspase recruitment domain (CARD) protein; Inhibitory caspaserecruitment domain protein.